乌尔索迪醇口服复合物悬浮剂的物理化学和微生物学稳定性
Kendice Ip1, Courtaney Davis2, Zainab Iqbal3
1Research and Development (KI, MC), PCCA, Houston, TX.
概括
这项研究发现,复合ursodiol口服悬浮剂在室温下稳定长达六个月. 这为无法吞固体剂型的儿科患者提供了安全有效的替代方案.
科学领域:
- 制药科学 制药科学
- 儿科配方 儿科配方 儿科配方
- 药物的稳定性 药物的稳定性
背景情况:
- 乌尔索迪醇主要以固体剂量形式提供,这对不能吞囊或片剂的儿科患者构成挑战.
- 需要适合儿童年龄的稳定口服配方,用于儿科的ursodiol.
- 随时制备口服悬浮剂提供了一个潜在的治疗替代方案.
研究的目的:
- 评估复合ursodiol口服悬浮剂的物理,化学和微生物稳定性.
- 为了确定超出使用日期 (BUD) 的临时准备的ursodiol悬浮液.
- 为药剂师提供针对儿科配方的验证稳定性数据.
主要方法:
- 使用商业囊和专有悬浮载体的ursodiol (20-60 mg/mL) 复合口服悬浮剂.
- 用稳定性指标分析方法来确定BUD.
- 物理特征包括外观,颜色和pH测试.
- 根据USP第51章评估了微生物学稳定性.
主要成果:
- 复合的ursodiol悬浮剂保持着均的白色外观,没有显著的pH值变化.
- 在整个研究过程中,功效保持在规格的±10%.
- 没有观察到挑战微生物的生长,这表明微生物的稳定性.
结论:
- 乌尔索迪醇复合口服悬浮剂在室温下在物理,化学和微生物学上保持长达6个月的稳定.
- 这种配方为儿科患者提供了可行的和稳定的选择.
- 经过验证的稳定性数据支持临时制备ursodiol口服悬浮剂.
相关概念视频
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
174
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
174
Factors Influencing Drug Absorption: Pharmaceutical Parameters
119
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
119
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
284
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
284
Factors Influencing Drug Absorption: Drug Dissolution
415
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
415
Factors Influencing Drug Absorption: Physicochemical Parameters
225
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
225
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.1K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.1K


